Literature DB >> 6165276

The role of interferon in immediate hypersensitivity and autoimmune diseases.

J J Hooks, H M Moutsopoulos, A L Notkins.   

Abstract

We have presented evidence showing that interferon can enhance the IgE-mediated release of histamine. We have also shown that immune interferon is present in the circulation of patients with certain autoimmune diseases. Furthermore, there is a positive correlation between active systemic lupus erythematosus and interferon levels. Systemic lupus erythematosus is characterized by immune hyperactivity. The continuous presence of type II, immune interferon in the circulation of these patients may, on one hand, contribute to the immunological aberrations, while on the other hand, protect against viral infections. At the present time we are looking for interferon in the circulation of patients with other autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6165276     DOI: 10.1111/j.1749-6632.1980.tb20603.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology.

Authors:  J B Harley; R H Scofield
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

3.  Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease.

Authors:  K Hamzaoui; K Ayed; A Slim; M Hamza; J Touraine
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

4.  [Detection of nephrotoxicity of human alpha 2b interferon with special reference to the analysis of urine enzymes in patients with chronic myeloid leukemia].

Authors:  E Kurschel; U Metz-Kurschel; W Hofmann; N Niederle
Journal:  Klin Wochenschr       Date:  1987-07-15

5.  Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.

Authors:  L Gabriele; T Kaido; D Woodrow; J Moss; M Ferrantini; E Proletti; L Santodonato; C Rozera; C Maury; F Belardelli
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

Review 6.  Interferon triggers experimental synovitis and may potentiate auto-immune disease in humans.

Authors:  T O Rosenbach; S Moshonov; U Zor; M Yaron
Journal:  Clin Rheumatol       Date:  1984-09       Impact factor: 2.980

7.  Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study.

Authors:  Gillian I Rice; Gabriella M A Forte; Marcin Szynkiewicz; Diana S Chase; Alec Aeby; Mohamed S Abdel-Hamid; Sam Ackroyd; Rebecca Allcock; Kathryn M Bailey; Umberto Balottin; Christine Barnerias; Genevieve Bernard; Christine Bodemer; Maria P Botella; Cristina Cereda; Kate E Chandler; Lyvia Dabydeen; Russell C Dale; Corinne De Laet; Christian G E L De Goede; Mireia Del Toro; Laila Effat; Noemi Nunez Enamorado; Elisa Fazzi; Blanca Gener; Madli Haldre; Jean-Pierre S-M Lin; John H Livingston; Charles Marques Lourenco; Wilson Marques; Patrick Oades; Pärt Peterson; Magnhild Rasmussen; Agathe Roubertie; Johanna Loewenstein Schmidt; Stavit A Shalev; Rogelio Simon; Ronen Spiegel; Kathryn J Swoboda; Samia A Temtamy; Grace Vassallo; Catheline N Vilain; Julie Vogt; Vanessa Wermenbol; William P Whitehouse; Doriette Soler; Ivana Olivieri; Simona Orcesi; Mona S Aglan; Maha S Zaki; Ghada M H Abdel-Salam; Adeline Vanderver; Kai Kisand; Flore Rozenberg; Pierre Lebon; Yanick J Crow
Journal:  Lancet Neurol       Date:  2013-10-30       Impact factor: 44.182

Review 8.  Virus-related pathology: is the continued presence of the virus necessary?

Authors:  J Huppert; T F Wild
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

9.  Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile.

Authors:  A M Yee; J P Buyon; Y K Yip
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.